UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 53

Sortiert nach

Bridging the gap: A priorities assessment tool to support shared decision making, maximize limited appointment time and increase patient satisfaction

Gynecologic oncology, 2017-06, Vol.145, p.48-49

2017

Link zum Volltext

Verfügbarkeit prüfen

Survivors' acceptance of treatment side effects evolves as goals of care change over the cancer continuum

Gynecologic oncology, 2016-06, Vol.141, p.23-23

2016

Link zum Volltext

Verfügbarkeit prüfen

Rescreening for genetic mutations using multi-gene panel testing in patients who previously underwent noninformative genetic screening

Gynecologic oncology, 2015-04, Vol.137, p.58-58

2015

Link zum Volltext

Verfügbarkeit prüfen

Indication for robotic-assisted surgery influences perioperative outcomes and hospital readmissions among women undergoing gynecologic procedures

Gynecologic oncology, 2017-06, Vol.145, p.145-146

2017

Link zum Volltext

Verfügbarkeit prüfen

Reoperation and recurrence rates in women undergoing conservative surgery for low malignant potential tumors

Gynecologic oncology, 2017-06, Vol.145, p.39-39

2017

Link zum Volltext

Verfügbarkeit prüfen

Prospective evaluation of a facilitated referral pathway to improve uptake of genetic assessment for women with newly diagnosed ovarian cancer

Gynecologic oncology, 2017-06, Vol.145, p.149-150

2017

Link zum Volltext

Verfügbarkeit prüfen

Safety of robotic-assisted gynecologic surgery and early hospital discharge in elderly patients

Gynecologic oncology, 2017-06, Vol.145, p.178-178

2017

Link zum Volltext

Verfügbarkeit prüfen

How old is too old: Safety of minimally invasive gynecologic surgery and early hospital discharge in the oldest elderly

Gynecologic oncology, 2017-06, Vol.145, p.140-141

2017

Link zum Volltext

Verfügbarkeit prüfen

Higher rates of clinically actionable multigene panel results in Ashkenazi Jewish patients

Gynecologic oncology, 2016-06, Vol.141, p.10-10

2016

Link zum Volltext

Verfügbarkeit prüfen

The efficacy of mTORC1/2 inhibition on ovarian cancer stem cells

Gynecologic oncology, 2016-06, Vol.141, p.110-110

2016

Link zum Volltext

Verfügbarkeit prüfen

Dual mTORC1/2 inhibitor INK128 potentiates sensitivity to carboplatin in a platinum resistant ovarian cancer cell line

Gynecologic oncology, 2015-04, Vol.137, p.203-204

2015

Link zum Volltext

Verfügbarkeit prüfen

The role of intraperitoneal platinum-based therapy and anti-angiogenic agents in primary ovarian cancer treatment for BRCA positive patients

Gynecologic oncology, 2017-06, Vol.145, p.74-75

2017

Link zum Volltext

Verfügbarkeit prüfen

Predictors of port site hernia necessitating operative intervention in patients undergoing robotic surgery

Gynecologic oncology, 2017-06, Vol.145, p.176-176

2017

Link zum Volltext

Verfügbarkeit prüfen

Final analysis of overall survival in OCEANS, a randomized phase III trial of gemcitabine, carboplatin, and bevacizumab followed by bevacizumab until disease progression in patients with platinum-sensitive recurrent ovarian cancer

Gynecologic oncology, 2014-06, Vol.133, p.57-57

2014

Link zum Volltext

Verfügbarkeit prüfen

mTOR complex inhibition as a novel therapeutic strategy in high-grade papillary serous ovarian cancer

Gynecologic oncology, 2014-06, Vol.133, p.119-120

2014

Link zum Volltext

Verfügbarkeit prüfen

Narrative medicine: Using reflective writing workshops to help house staff address the complex and challenging nature of caring for gynecologic oncology patients

Gynecologic oncology, 2014-06, Vol.133, p.73-73

2014

Link zum Volltext

Verfügbarkeit prüfen

Cross-sectional study on the impact of a natural disaster on delivery of gynecologic oncology care

Gynecologic oncology, 2014-06, Vol.133, p.150-150

2014

Link zum Volltext

Verfügbarkeit prüfen

Outcomes for High-Dose-Rate (HDR) Brachytherapy in the Treatment of Cervical Cancer

International journal of radiation oncology, biology, physics, 2013-10, Vol.87 (2), p.S406-S406

2013

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic targeting of PTK6 oncogene in ovarian cancer

Gynecologic oncology, 2020-10, Vol.159, p.84-84

2020

Link zum Volltext

Verfügbarkeit prüfen

Efficacy in Patient Subgroups in OCEANS, a Randomized, Double-blinded, Placebo-controlled, Phase 3 Trial of Chemotherapy ± Bevacizumab in Patients with Platinum-sensitive Recurrent Epithelial Ovarian (OC), Primary Peritoneal (PPC), or Fallopian Tube Cancer (FTC)

European journal of cancer (1990), 2011, Vol.47, p.5-5

2011

Link zum Volltext

Verfügbarkeit prüfen

Germline and somatic testing for ovarian Cancer: An SGO clinical practice statement

Gynecologic oncology, 2024-02, Vol.181, p.170-178

2024

Link zum Volltext

Verfügbarkeit prüfen

Corrigendum to abstract “Lymph node dissection in surgical management of atypical endometrial hyperplasia” [Gynecol. Oncol. 112 (2009) S78–S79]

Gynecologic oncology, 2009-05, Vol.113 (2), p.298-298

2009

Link zum Volltext

Verfügbarkeit prüfen

Creating work environments where people of all genders in gynecologic oncology can thrive: An SGO evidence-based review

Gynecologic oncology, 2022-03, Vol.164 (3), p.473-480

2022

Link zum Volltext

Verfügbarkeit prüfen

Factors influencing time interval between diagnosis and primary surgical management of endometrial cancer

Gynecologic oncology, 2019-06, Vol.154, p.125-126

2019

Link zum Volltext

Verfügbarkeit prüfen

What happens in the real world? Assessment of two screening tools for Lynch syndrome in patients with endometrial cancer: Universal tumor testing versus clinical screening

Gynecologic oncology, 2019-06, Vol.154, p.220-221

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 53

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(53)
Mit Volltextzugriff
(53)

Publikationsform

Artikel
(53)

Sprache

Englisch
(53)

Erscheinungsjahr

n.n

Thema

Hematology, Oncology And Palliative Medicine
(20)
Obstetrics And Gynecology
(18)
Science & Technology
(11)
Life Sciences & Biomedicine
(7)
Biochemistry & Molecular Biology
(4)
Genetics & Heredity
(4)
Issr
(4)
Microsatellite Repeats
(4)
Female
(3)
Humans
(3)
Obstetrics & Gynecology
(3)
Oncology
(3)
Physical Sciences
(3)
Polymorphism, Genetic
(3)
Analytical Chemistry
(2)
Chemistry
(2)
Diversity
(2)
Gene Polymorphism
(2)
Genetic Variability
(2)
Genital Neoplasms, Female - Therapy
(2)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Bridging the gap: A priorities assessment tool to support shared decision making, maximize limited appointment time and increase patient satisfaction

Survivors' acceptance of treatment side effects evolves as goals of care change over the cancer continuum

Rescreening for genetic mutations using multi-gene panel testing in patients who previously underwent noninformative genetic screening

Indication for robotic-assisted surgery influences perioperative outcomes and hospital readmissions among women undergoing gynecologic procedures

Reoperation and recurrence rates in women undergoing conservative surgery for low malignant potential tumors

Prospective evaluation of a facilitated referral pathway to improve uptake of genetic assessment for women with newly diagnosed ovarian cancer

Safety of robotic-assisted gynecologic surgery and early hospital discharge in elderly patients

How old is too old: Safety of minimally invasive gynecologic surgery and early hospital discharge in the oldest elderly

Higher rates of clinically actionable multigene panel results in Ashkenazi Jewish patients

The efficacy of mTORC1/2 inhibition on ovarian cancer stem cells

Dual mTORC1/2 inhibitor INK128 potentiates sensitivity to carboplatin in a platinum resistant ovarian cancer cell line

The role of intraperitoneal platinum-based therapy and anti-angiogenic agents in primary ovarian cancer treatment for BRCA positive patients

Predictors of port site hernia necessitating operative intervention in patients undergoing robotic surgery

Final analysis of overall survival in OCEANS, a randomized phase III trial of gemcitabine, carboplatin, and bevacizumab followed by bevacizumab until disease progression in patients with platinum-sensitive recurrent ovarian cancer

mTOR complex inhibition as a novel therapeutic strategy in high-grade papillary serous ovarian cancer

Narrative medicine: Using reflective writing workshops to help house staff address the complex and challenging nature of caring for gynecologic oncology patients

Cross-sectional study on the impact of a natural disaster on delivery of gynecologic oncology care

Outcomes for High-Dose-Rate (HDR) Brachytherapy in the Treatment of Cervical Cancer

Therapeutic targeting of PTK6 oncogene in ovarian cancer

Efficacy in Patient Subgroups in OCEANS, a Randomized, Double-blinded, Placebo-controlled, Phase 3 Trial of Chemotherapy ± Bevacizumab in Patients with Platinum-sensitive Recurrent Epithelial Ovarian (OC), Primary Peritoneal (PPC), or Fallopian Tube Cancer (FTC)

Germline and somatic testing for ovarian Cancer: An SGO clinical practice statement

Corrigendum to abstract “Lymph node dissection in surgical management of atypical endometrial hyperplasia” [Gynecol. Oncol. 112 (2009) S78–S79]

Creating work environments where people of all genders in gynecologic oncology can thrive: An SGO evidence-based review

Factors influencing time interval between diagnosis and primary surgical management of endometrial cancer

What happens in the real world? Assessment of two screening tools for Lynch syndrome in patients with endometrial cancer: Universal tumor testing versus clinical screening

Suchergebnisse filtern